Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or North Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to North Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. North Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Henry Holt (NPI 1417237884)

Field	Value
Entity Type	Individual
Organization	Henry Holt
Address	1801 New Hanover Medical Park Dr
City	Wilmington
State	NC
ZIP	28403
Taxonomy	Ophthalmology Physician
NPI Enumerated	August 17, 2011

Payer Source	Total Paid
Medicare	$2.7M
Medicaid	$0

Key Findings

This provider’s Medicare practice is highly concentrated in intravitreal injection services and related drug administration: the top three Medicare codes (J0178, J2777, J3490) account for 82.3% of Medicare revenue, with J0178 alone representing $1.4M (50.5% of Medicare revenue) and J2777 contributing $671.6K (25.1%). That concentration indicates the business is primarily procedural and drug-revenue driven rather than visit- or evaluation-heavy.

Operationally the code mix points to a retina-focused ophthalmology practice that delivers high volumes of anti-VEGF and related intravitreal therapies: J0178 (aflibercept) and J2777 (faricimab) are the largest revenue drivers by far, and 67028 is also present as a common injection procedure code. The presence of substantial J3490 revenue ($182K, 6.8%) as the third-largest Medicare source suggests material billing for unclassified drug administration or miscellaneous drug charges within the injection workflow.

Payer mix is effectively single‑payer Medicare: lifetime Medicare revenue is $2.7M while Medicaid shows none on file, so analysts should treat this entity as Medicare-dependent for public-payer volume and revenue comparisons. This lack of Medicaid billing reduces exposure to state Medicaid rate and utilization dynamics and simplifies payer-revenue analysis to Medicare-only trends.

Competitive standing on the nation-wide stage is mixed: the provider’s J0178 volume ranks #555 of 3204 providers (83th percentile) and J2777 ranks #435 of 2039 providers (79th percentile), both described as “typical, unremarkable volume,” which characterizes the provider as a modest national participant rather than a dominant injector. By contrast, the provider is a clear high outlier on diagnostic imaging and established-patient visits — 92134 ranks in the 97th percentile (labeled “extreme outlier”) and 92014 is in the 96th percentile (labeled “notably above typical national volume”), indicating disproportionate retinal imaging and follow-up exam activity relative to peers.

The high percentile ranks for 92134 (97th, extreme outlier) and 92014 (96th, notably above typical) alongside the injection-dominated revenue profile suggest a workflow that pairs frequent retinal imaging with procedural administration of drug therapies. This combination is consistent with a retina subspecialty practice that both monitors chronic retinal disease closely and manages it with recurring intravitreal injections.

Although injections are the main revenue source, many commonly billed office E/M codes show only modest revenue share (for example 99213 contributed $19.3K and 99214 contributed $5.6K), indicating that the practice’s revenue model leans more heavily on procedures and drugs than on E/M throughput. Analysts should interpret encounter-level visit revenue as secondary to procedure/drug revenue when modeling margins or visit-to-procedure conversion.

There are no clear indications of statewide Medicaid activity or market share because Medicaid billing is absent; competitive analysis within North Carolina Medicaid should therefore rely on other providers for comparisons. For Medicare-focused network decisions or contracting, this provider’s procedural and imaging volumes are the most relevant metrics given the absence of Medicaid claims.

Provider tenure is well established: the NPI was enumerated on 2011-08-17 (~15 years ago), which supports the interpretation that current billing patterns reflect a stable practice rather than a recent startup or transient provider. That longevity, combined with the concentrated injection and imaging mix, strengthens the case that these are persistent operational characteristics rather than short-term anomalies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,960	$690	$1.4M
J2777	Injection, faricimab‑svoa, 0.1 mg	23,160	$30	$671.6K
J3490	Unclassified drugs	90	$2,140	$182K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,510	$80	$125.6K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,080	$90	$95.1K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,340	$30	$68K
J2778	Injection, ranibizumab, 0.1 mg	300	$180	$53.7K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	260	$160	$40.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	310	$60	$19.3K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	160	$110	$17K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. North Carolina Distribution

Henry Holt — 3 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — North Carolina

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	23	100	950	$690	$881K
J2777	21	70	12,990	$30	$503.7K
J2778	37	50	620	$180	$202.2K
67028	29	120	780	$90	$80K
J7312	12	20	390	$160	$56.4K
J3490	15	80	50	$450	$24.1K
92014	27	880	110	$80	$17.7K
67036	19	20	20	$840	$16.7K
99214	12,429	18,060	110	$80	$15.1K
J9035	63	90	140	$50	$13.4K

Showing 1–10 of 24

Related Providers

Other providers that share a Tax Identification Number (TIN) with Henry Holt, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Igor Westra	NC	Retina Specialist (Ophthalmology) Physician	$2.6M	$0
John Deans	NC	Ophthalmology Physician	$2.4M	$0

Nearby Providers

Other providers in the same ZIP code as Henry Holt, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Wilmington Medical Supply Inc	NC	Durable Medical Equipment & Medical Supplies	$0	$47.8M
A2z Home Medical Supplies, Inc	NC	Durable Medical Equipment & Medical Supplies	$0	$47.4M
Maxim Healthcare Services, Inc.	NC	Home Health Agency	$0	$33.8M
Bayada Home Health Care, Inc.	NC	Home Health Agency	$0	$28.3M
Physician Alliance For Mental Health, LLC	NC	Community/Behavioral Health Agency	$0	$28M
Easter Seals Ucp North Carolina & Virgiinia, Inc.	NC	Community/Behavioral Health Agency	$0	$19.2M
Bayada Home Health Care, Inc.	NC	Developmental Disabilities Clinic/Center	$0	$18M
Therapy Works Of Wilmington	NC	Speech-Language Pathologist	$0	$12.2M
Coastline Therapy Group, LLC	NC	Speech-Language Pathologist	$0	$11.8M
Pd Of Wilmington Inc	NC	In Home Supportive Care Agency	$0	$11.4M

Henry Holt — Billing Profile & Reimbursement Data

Sign up for Henry Holt — Billing Profile & Reimbursement Data policy alerts

Henry Holt — Billing Profile & Reimbursement Data

Sign up for Henry Holt — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References